Literature DB >> 10415718

Evaluation of some newer matrix metalloproteinases.

G Murphy1, V Knäuper, S Cowell, R Hembry, H Stanton, G Butler, J Freije, A M Pendás, C López-Otín.   

Abstract

Recombinant protein expression techniques have been utilized to facilitate the biochemical and cell biological characterization of human matrix metalloproteinases (MMPs). The importance of the membrane type 1 MMP (MMP 14) in the regulation of pericellular proteolysis, either directly or through the activation of MMP-2, MMP-9, and MMP-13 has been identified. Studies on an in vitro chondrocyte-like cell and an in vivo cartilage repair model indicated that such MT1 MMP-regulated activation cascades are physiologically feasible. MMP19 shows a limited sequence identity with other MMPs and may represent a novel subclass. However, analysis of the recombinant protein identified a number of biochemical properties typical of the MMP family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415718     DOI: 10.1111/j.1749-6632.1999.tb07672.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  24 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.

Authors:  Anika Agarwal; Lidija Covic; Leila M Sevigny; Nicole C Kaneider; Katherine Lazarides; Gissou Azabdaftari; Sheida Sharifi; Athan Kuliopulos
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

3.  Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes.

Authors:  Stephen J Fortunato; Ramkumar Menon
Journal:  J Assist Reprod Genet       Date:  2002-10       Impact factor: 3.412

4.  Genetic variation in matrix metalloproteinase MMP2 and MMP9 as a risk factor for idiopathic recurrent spontaneous abortions in an Indian population.

Authors:  Deepika Ramu; Vettriselvi Venkatesan; Solomon Franklin Durairaj Paul; Teena Koshy
Journal:  J Assist Reprod Genet       Date:  2017-05-12       Impact factor: 3.412

Review 5.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

6.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

Authors:  E Toschi; G Barillari; C Sgadari; I Bacigalupo; A Cereseto; D Carlei; C Palladino; C Zietz; P Leone; M Stürzl; S Buttò; A Cafaro; P Monini; B Ensoli
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

Review 7.  Ovarian cancer: involvement of the matrix metalloproteinases.

Authors:  Linah Al-Alem; Thomas E Curry
Journal:  Reproduction       Date:  2015-04-27       Impact factor: 3.906

8.  [Expression of matrix metalloproteinase-19 in the human cornea. Wound healing in the MMP-19 knock-out mouse model].

Authors:  F Treumer; C Flöhr; A Klettner; B Nölle; J Roider
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

9.  Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease.

Authors:  J Brynskov; P Foegh; G Pedersen; C Ellervik; T Kirkegaard; A Bingham; T Saermark
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo.

Authors:  Christine Chabasse; Suzanne A Siefert; Mohammed Chaudry; Mark H Hoofnagle; Brajesh K Lal; Rajabrata Sarkar
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2014-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.